Clinical Trial Detail

NCT ID NCT01876511
Title Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

colorectal cancer

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.